Basal or bolus dose, which is the key factor in CSII? / 浙江大学学报(英文版)(B辑:生物医学和生物技术)
Journal of Zhejiang University. Science. B
;
(12): 763-765, 2006.
Artículo
en Inglés
| WPRIM
| ID: wpr-251857
ABSTRACT
<p><b>OBJECTIVE</b>To observe the value of HbA(1)c level evaluating the total daily basal insulin dose by continuous subcutaneous insulin infusion (CSII) in 268 patients with type 2 diabetes mellitus.</p><p><b>METHODS</b>5-point capillary blood glucose was monitored in pre- and post-CSII and the insulin dose which could stabilize blood glucose was defined as the total daily dose of insulin, including basal and bolus total dose. Correlation between HbA(1)c level and total daily dose of insulin in patients with type 2 diabetes mellitus was analyzed. Correlation between HbA(1)c level and 5-point capillary blood glucose was also analyzed.</p><p><b>RESULTS</b>Obvious correlation was observed between HbA(1)c level and the basal total daily dose of insulin if HbA(1)c was more than 9.3% (r=0.635, P<0.05). The average of 5-point capillary blood glucose was best correlated with HbA(1)c and fasting blood glucose next best.</p><p><b>CONCLUSION</b>HbA(1)c level can forecast basal total daily dose of insulin in CSII.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Glucemia
/
Hemoglobina Glucada
/
Insulina
Límite:
Anciano
/
Aged80
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Journal of Zhejiang University. Science. B
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS